FULC
Fulcrum Therapeutics, Inc. · Healthcare
Interim Pres, CEO Robert J Gould sold $101K of Fulcrum Therapeutics, Inc.
Sold$101,490
$15.00Price
6,766Shares
−1%Stake
What FULC did after the filing
- The stock from Fri, Jan 13 close, $13.70
- −55.9%
- S&P 500, same days
- −0.6%
Measured over 30 trading days, to the Feb 28 close.
Traded Fri, Jan 13. Filed Fri, Jan 13, 1:33 PM ET, during the session. Returns use the Jan 13 close and the Feb 28 close. Not investment advice.